EGFR c.2327G>T ;(p.R776L)

Variant ID: 7-55249029-G-T

NM_005228.3(EGFR):c.2327G>T;(p.R776L)

This variant was identified in 5 publications

View GRCh38 version.




Publications:


Various Subtypes of EGFR Mutations in Patients With NSCLC Define Genetic, Immunologic Diversity and Possess Different Prognostic Biomarkers.

Frontiers In Immunology
Lei, Youming Y; Wang, Kun K; Liu, Yinqiang Y; Wang, Xuming X; Xiang, Xudong X; Ning, Xiangu X; Ding, Wanbao W; Duan, Jin J; Li, Dingbiao D; Zhao, Wei W; Li, Yi Y; Zhang, Fujun F; Luo, Xiaoyu X; Shi, Yunfei Y; Wang, Ying Y; Huang, Depei D; Bai, Yuezong Y; Zhang, Hushan H
Publication Date: 2022

Variant appearance in text: EGFR: R776L
PubMed Link: 35265073
Variant Present in the following documents:
  • Main text
  • fimmu-13-811601.pdf
View BVdb publication page



A Nationwide Study on the Impact of Routine Testing for EGFR Mutations in Advanced NSCLC Reveals Distinct Survival Patterns Based on EGFR Mutation Subclasses.

Cancers
Koopman, Bart B; Cajiao Garcia, Betzabel N BN; Kuijpers, Chantal C H J CCHJ; Damhuis, Ronald A M RAM; van der Wekken, Anthonie J AJ; Groen, Harry J M HJM; Schuuring, Ed E; Willems, Stefan M SM; van Kempen, Léon C LC
Publication Date: 2021-07-20

Variant appearance in text: EGFR: R776L
PubMed Link: 34298851
Variant Present in the following documents:
  • Main text
  • cancers-13-03641.pdf
View BVdb publication page



Non-classic EGFR mutations in a cohort of Dutch EGFR-mutated NSCLC patients and outcomes following EGFR-TKI treatment.

British Journal Of Cancer
Kuiper, J L JL; Hashemi, S M S SM; Thunnissen, E E; Snijders, P J F PJ; Grünberg, K K; Bloemena, E E; Sie, D D; Postmus, P E PE; Heideman, D A M DA; Smit, E F EF
Publication Date: 2016-12-06

Variant appearance in text: EGFR: R776L
PubMed Link: 27875527
Variant Present in the following documents:
  • Main text
  • bjc2016372a.pdf
View BVdb publication page



Erlotinib in African Americans with advanced non-small cell lung cancer: a prospective randomized study with genetic and pharmacokinetic analyses.

Clinical Pharmacology And Therapeutics
Phelps, M A MA; Stinchcombe, T E TE; Blachly, J S JS; Zhao, W W; Schaaf, L J LJ; Starrett, S L SL; Wei, L L; Poi, M M; Wang, D D; Papp, A A; Aimiuwu, J J; Gao, Y Y; Li, J J; Otterson, G A GA; Hicks, W J WJ; Socinski, M A MA; Villalona-Calero, M A MA
Publication Date: 2014-08

Variant appearance in text: EGFR: R776L
PubMed Link: 24781527
Variant Present in the following documents:
  • Main text
View BVdb publication page



Variability in organ-specific EGFR mutational spectra in tumour epithelium and stroma may be the biological basis for differential responses to tyrosine kinase inhibitors.

British Journal Of Cancer
Weber, F F; Fukino, K K; Sawada, T T; Williams, N N; Sweet, K K; Brena, R M RM; Plass, C C; Caldes, T T; Mutter, G L GL; Villalona-Calero, M A MA; Eng, C C
Publication Date: 2005-05-23

Variant appearance in text: EGFR: R776L
PubMed Link: 15841079
Variant Present in the following documents:
  • Main text
  • 92-6602557a.pdf
View BVdb publication page